U.S. investors, Big Pharma race to find new medicines in China

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector transforms.U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector transforms.